Shane A. Bobart, MD; Benjamin Gleason, MD; Nydia Martinez, MD; Keith Norris, MD, PhD; Sandra F. Williams, MD
Presented in part at the American College of Physicians' 2015 Florida Annual Chapter Scientific Meeting, Tampa, Florida, 11–13 September 2015.
Acknowledgment: The authors thank Jonathan Schroeder, MD.
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L15-0535.
Bobart SA, Gleason B, Martinez N, et al. Euglycemic Ketoacidosis Caused by Sodium–Glucose Cotransporter 2 Inhibitors: A Case Report. Ann Intern Med. 2016;165:530–532. doi: https://doi.org/10.7326/L15-0535
Download citation file:
Published: Ann Intern Med. 2016;165(7):530-532.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use